2008
DOI: 10.1016/j.ejso.2007.07.210
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic therapy in the management of malignant biliary obstruction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
30
0
12

Year Published

2008
2008
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(42 citation statements)
references
References 31 publications
0
30
0
12
Order By: Relevance
“…A photosensitizing agent is employed, which accumulates in proliferating tissue. Following illumination with a laser, free radicals are generated, resulting in necrosis and apoptosis of cells [106]. Tissue necrosis is typically achieved at a depth of 4-6 mm, and the destructive effect can be augmented by the delivery of systemic oxygen [106].…”
Section: Photodynamic Therapymentioning
confidence: 99%
See 1 more Smart Citation
“…A photosensitizing agent is employed, which accumulates in proliferating tissue. Following illumination with a laser, free radicals are generated, resulting in necrosis and apoptosis of cells [106]. Tissue necrosis is typically achieved at a depth of 4-6 mm, and the destructive effect can be augmented by the delivery of systemic oxygen [106].…”
Section: Photodynamic Therapymentioning
confidence: 99%
“…Following illumination with a laser, free radicals are generated, resulting in necrosis and apoptosis of cells [106]. Tissue necrosis is typically achieved at a depth of 4-6 mm, and the destructive effect can be augmented by the delivery of systemic oxygen [106]. Photodynamic therapy can be used as primary therapy to control tumor growth and to prolong the patency rates of biliary endoprostheses.…”
Section: Photodynamic Therapymentioning
confidence: 99%
“…[13][14][15][16] A number of factors have been suggested to explain this relatively high failure rate, including epithelial hyperplasia, tumor ingrowth and overgrowth, dislocation, debris formation, and clot accumulation. 1,17,18 To better counteract tumor ingrowth in uncovered SEMSs (uSEMSs), covered SEMSs (cSEMSs) were developed by placing a thin nonporous membrane on the inside of the metal mesh. Possible advantages of such a stent design have so far been addressed in relatively few small clinical studies, and the results have been partly conflicting.…”
mentioning
confidence: 99%
“…PTCD is a common choice of therapy when surgical or endoscopic therapies were unsuccessful or unsuitable [3][4][5] . However, following PTCD, patients have to carry a drainage pack for a long time which is inconvenient.…”
Section: Discussionmentioning
confidence: 99%